Retirada de medicación antiepiléptica

Egileak

  • L. Pulido Fontes Servicio de Neurología. Complejo Hospitalario de Navarra. Pamplona (Navarra). España
  • M. Pulido Fontes Servicio de Neurología. Complejo Hospitalario de Navarra. Pamplona (Navarra). España

##plugins.pubIds.doi.readerDisplayName##:

https://doi.org/10.23938/ASSN.0966

Gako-hitzak:

Fármacos antiepilépticos

##plugins.generic.usageStats.downloads##

##plugins.generic.usageStats.noStats##

Erreferentziak

SHORVON SD, GOODRIDGE DM. Longitudinal cohort studies of the prognosis of epilepsy: contribution of the National General Practice Study of Epilepsy and other studies. Brain 2013; 136: 3497-510. https://doi.org/10.1093/brain/awt223

LAMBERINK HJ, OTTE WM, GELEIJNS K, BRAUN KP. Antiepileptic drug withdrawal in medically and surgically treated patients: a meta-analysis of seizure recurrence and systematic review of its predictors. Epileptic Disord 2015; 17: 211-228. https://doi.org/10.1684/epd.2015.0764

LAMBERINK HJ, OTTE WM, GEERTS AT, PAVLOVIC M, RAMOS-LIZANA J, MARSON AG et al. Individualised prediction model of seizure recurrence and long-term outcomes after withdrawal of antiepileptic drugs in seizure-free patients: a systematic review and individual participant data meta-analysis. Lancet Neurol 2017; 16: 523-531. https://doi.org/10.1016/s1474-4422(17)30114-x

MARTÍNEZ-JUÁREZ IE, ALONSO ME, MEDINA MT, DURÓN RM, BAILEY JN, LÓPEZ-RUIZ M et al. Juvenile myoclonic epilepsy subsyndromes: family studies and long-term follow-up. Brain 2006; 129: 1269-1280. https://doi.org/10.1093/brain/awl048

VILORIA ALEBESQUE A, BELLOSTA DIAGO E, SANTOS LASAOSA S, MAURI LLERDA JA. Epilepsia mioclónica juvenil: pronóstico a largo plazo y retirada de tratamiento. An Sist Sanit Navar 2020; 43: 43-49. https://doi.org/10.23938/ASSN.0756

Argitaratuta

2021-08-20

Zenbakia

Atala

Cartas al editor